Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Children and Adolescents With Autistic Disorder
NCT01308749Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2011
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by University of North Carolina at Chapel Hill. Started Mar 2011; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01308749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01308749.